Nahouraii Lauren M, Allen Jordan L, Merrill Suzanne B, Lehman Erik, Kaag Matthew G, Raman Jay D
College of Medicine, Pennsylvania State University, Hershey, PA, USA.
Division of Urology, Department of Surgery, Penn State College of Medicine, Hershey, PA, USA.
J Kidney Cancer VHL. 2020 Aug 25;7(3):20-25. doi: 10.15586/jkcvhl.2020.134. eCollection 2020.
Pathologic characteristics of extirpated renal cell carcinoma (RCC) specimens <7 cm were reviewed to get better information on technical nuances of renal mass biopsy (RMB). Specimens were stratified according to tumor stage, nuclear grade, size, histology, presence of lymphovascular invasion (LVI), necrosis, and sarcomatoid features. When considering pT1 (0-7 cm) tumors, pT1b (4-7 cm) RCC masses were more likely to have necrosis (43% vs 16%, P < 0.001), LVI (6% vs 2%, P = 0.024), high-grade nuclear elements (29% vs 17%, P < 0.001), and sarcomatoid features (2% vs 0%, P = 0.006) compared with pT1a (0-4 cm) tumors. Additionally, pT3a tumors were more highly associated with necrosis (P = 0.005), LVI, sarcomatoid features, and high-grade disease (P for all < 0.001) when compared to pT1 masses. For masses <4 cm, pT3a cancers were more likely to demonstrate necrosis (38% vs 16%, P < 0.001), LVI (22% vs 2%, P < 0.001), high-grade nuclear elements (45% vs 17%, P < 0.001), and sarcomatoid features (12% vs 0%, P < 0.001) compared to pT1a tumors. Similarly, for masses 4-7 cm, pathologic T3a tumors were significantly more likely to have sarcomatoid features (12% vs 2%, P = 0.006) and LVI (22% vs 6%, P = 0.003) compared to pT1b tumors. In summary, pT3a tumors and those RCC masses >4 cm exhibit considerable histologic heterogeneity and may harbor elements that are not easily appreciated with limited renal sampling. Therefore, if RMB is considered for renal masses greater than 4 cm or those that abut sinus fat, a multi-quadrant biopsy approach is necessary to ensure adequate sampling and characterization of the mass.
对切除的直径小于7cm的肾细胞癌(RCC)标本的病理特征进行回顾,以更好地了解肾肿块活检(RMB)的技术细节。标本根据肿瘤分期、核分级、大小、组织学、是否存在脉管侵犯(LVI)、坏死和肉瘤样特征进行分层。在考虑pT1(0 - 7cm)肿瘤时,与pT1a(0 - 4cm)肿瘤相比,pT1b(4 - 7cm)RCC肿块更有可能出现坏死(43%对16%,P < 0.001)、LVI(6%对2%,P = 0.024)、高级别核成分(29%对17%,P < 0.001)和肉瘤样特征(2%对0%,P = 0.006)。此外,与pT1肿块相比,pT3a肿瘤与坏死(P = 0.005)、LVI、肉瘤样特征和高级别疾病(所有P < 0.001)的相关性更高。对于直径小于4cm的肿块,与pT1a肿瘤相比,pT3a癌症更有可能表现出坏死(38%对16%,P < 0.001)、LVI(22%对2%,P < 0.001)、高级别核成分(45%对17%,P < 0.001)和肉瘤样特征(12%对0%,P < 0.001)。同样,对于直径4 - 7cm的肿块,与pT1b肿瘤相比,病理T3a肿瘤更有可能具有肉瘤样特征(12%对2%,P = 0.006)和LVI(22%对6%,P = 0.003)。总之,pT3a肿瘤和那些直径大于4cm的RCC肿块表现出相当大的组织学异质性,并且可能含有在有限的肾脏采样中不易识别的成分。因此,如果考虑对直径大于4cm或紧邻肾窦脂肪的肾肿块进行RMB,多象限活检方法是必要的,以确保对肿块进行充分采样和特征描述。